Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Healthtrust
Medtronic
Cipla
McKesson
Baxter
Deloitte
QuintilesIMS

Generated: April 26, 2018

DrugPatentWatch Database Preview

AUREOMYCIN Drug Profile

« Back to Dashboard

When do Aureomycin patents expire, and when can generic versions of Aureomycin launch?

Aureomycin is a drug marketed by Lederle and is included in one NDA.

The generic ingredient in AUREOMYCIN is chlortetracycline hydrochloride. There are twelve drug master file entries for this compound. Additional details are available on the chlortetracycline hydrochloride profile page.
Drug patent expirations by year for AUREOMYCIN
Medical Subject Heading (MeSH) Categories for AUREOMYCIN
Synonyms for AUREOMYCIN
(1/2)ethA(1)EO NIEaNI
(2E,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(2E,4S,4aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(2Z,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(2Z,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(2Z,4S,4aS,5aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(2Z,4S,4aS,6S,12aS)-2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(4S,4AS,5AS,6S,12AS)-7-CHLORO-4-(DIMETHYLAMINO)-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE HYDROCHLORIDE
(4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
(4S,4aS,6S,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride
101342-45-4
2-[amino(hydroxy)methylidene]-7-chloro-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
2-[azanyl(oxidanyl)methylidene]-7-chloranyl-4-(dimethylamino)-6-methyl-6,10,11,12a-tetrakis(oxidanyl)-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a- octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aS,5aS,6S,12aS)-
3671-08-7
4-epi-Chlortetracycline Hydrochloride
57-62-5 (Parent)
64-72-2
7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride
7-CHLORO-4-(DIMETHYLAMINO)-1,6,10,11,12A-PENTAHYDROXY-6-METHYL-3,12-DIOXO-3,4,4A,5,5A,6,12,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE HYDROCHLORIDE
7-Chlorotetracycline hydrochloride
7-Chlorotetracycline monohydrochloride
A834866
AB1009374
AC1NR05A
AC1NS0N6
AC1NUMIQ
AC1O4WFP
AC1O7FV5
AI3-50126
AKOS015951221
AN-23740
Aureocarmyl
Aureociclina
Aureocycline
Aureomycin (TN)
Aureomycin hydrochloride
Aureomycin hydrochloride;Chlortetracycline hydrochloride
Aureomycin monohydrochloride
Aureovit 12C80
Aurofac 100
Auxeomycin
B-Aureo
BB_NC-0684
Biomitsin hydrochloride
Biomycin hydrochloride
C22H23ClN2O8.HCl
C22H24Cl2N2O8
CAS-64-72-2
CCG-39737
CHEMBL1537344
CHEMBL2146063
Chlorotetracycline hydrochloride
Chlorotetracycline monohydrochloride, Antibiotic for Culture Media Use Only
Chlortetracycline (hydrochloride)
Chlortetracycline for system suitability, European Pharmacopoeia (EP) Reference Standard
Chlortetracycline HCl
Chlortetracycline hydrochloride
Chlortetracycline hydrochloride (JAN/USP)
Chlortetracycline hydrochloride [USAN:BAN]
Chlortetracycline hydrochloride [USP:BAN]
Chlortetracycline hydrochloride, >=75% (HPLC)
Chlortetracycline hydrochloride, BioReagent, suitable for fluorescence, from Streptomyces aureofaciens, >=97.0% (AT)
Chlortetracycline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Chlortetracycline Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Chlortetracycline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Chlortetracycline hydrochloride, VETRANAL(TM), analytical standard
Chlortetracycline Monohydrochloride
Chlortetracycline, monohydrochloride
Chlortetracyclinehydrochloride
Chlortetracyclinium chloride
Clorocipan
Clorotetraciclina cloridrato
Clorotetraciclina cloridrato [Italian]
CLTC
CLTC 100 MR
CS-4853
CTC
D02255
DSSTox_CID_25076
DSSTox_GSID_45076
DSSTox_RID_80653
DTXSID2045076
EINECS 200-591-7
EINECS 222-936-0
Fermycin Soluble
HMS1568M12
HMS1920M07
HY-B1327
Isphamycin
J10007
K043
KS-00000FWY
LS-174620
LS-93858
MCULE-1536837850
MCULE-2208752804
MFCD00082440
MLS001304009
MLS006011591
MolPort-003-665-528
MolPort-003-845-937
NCGC00016289-01
NCGC00256236-01
NSC-13252
NSC-756691
NSC13252
NSC756691
O1GX33ON8R
Pennchlor 64
Pharmakon1600-01500186
PL010147
PL030253
Prestwick_60
Psittacin hydrochloride
s4156
SCHEMBL3841
SMR000387083
SMR004703365
SPECTRUM1500186
SR-01000000011
SR-01000000011-2
Tetra 5
Tetracycline, 7-chloro-, hydrochloride
Tox21_110353
Tox21_301710
U-6780
UNII-O1GX33ON8R

US Patents and Regulatory Information for AUREOMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle AUREOMYCIN chlortetracycline hydrochloride OINTMENT;OPHTHALMIC 050404-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Federal Trade Commission
McKinsey
Merck
Accenture
Colorcon
Boehringer Ingelheim
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.